Journal of Chest Surgery

Journal of Chest Surgery Journal of Chest Surgery
Official page

Surgical Resection after Chemoradiotherapy with a Higher Radiation Dose in Locally Advanced Esophageal Cancer: A Retrosp...
13/11/2025

Surgical Resection after Chemoradiotherapy with a Higher Radiation Dose in Locally Advanced Esophageal Cancer: A Retrospective Study from Taiwan
J Chest Surg 2025; 58: 239-251
https://doi.org/10.5090/jcs.25.040

This study evaluates the outcomes of patients with locally advanced esophageal cancer who underwent surgery after high-dose neoadjuvant chemoradiotherapy (50.4 Gy). Nearly half of the patients achieved a pathologic complete response, which was strongly associated with significantly improved long-term survival. The results suggest that high-dose nCRT followed by surgery is safe and can offer substantial survival benefits, particularly for those achieving complete tumor eradication.

Epidermal Growth Factor Receptor Exon 20 Insertion in Early Resected Non-Small Cell Lung Cancer: A Retrospective, Single...
13/11/2025

Epidermal Growth Factor Receptor Exon 20 Insertion in Early Resected Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study in Taiwan
J Chest Surg 2025; 58: 227-236
https://doi.org/10.5090/jcs.25.027

This study evaluates the clinical outcomes of patients with resected NSCLC harboring EGFR exon 20 insertion mutations. The authors report that while disease-free survival is comparable to common EGFR mutations and wild type, overall survival is notably worse in the exon 20 insertion group. These patients tended to be younger and more frequently diagnosed at stage IA, yet showed a higher incidence of second primary cancers. Importantly, exon 20 insertion emerged as an independent predictor of mortality, underscoring the need for future development of effective adjuvant targeted therapies for this subgroup.



Read the commentary:
https://doi.org/10.5090/jcs.25.139

Evolution of Lung Cancer Surgery: Historical Milestones, Current Strategy, and Future InnovationsJ Chest Surg 2025; 58(3...
13/05/2025

Evolution of Lung Cancer Surgery: Historical Milestones, Current Strategy, and Future Innovations
J Chest Surg 2025; 58(3): 79-84
https://doi.org/10.5090/jcs.25.025

This manuscript reviews the historical milestones, current strategies, and future innovations in lung cancer surgery. It traces the evolution from early pneumonectomy to lobectomy as the standard for resectable non-small cell lung cancer (NSCLC), and highlights the growing role of sublobar resections, such as segmentectomy and wedge resection, for early-stage NSCLC.

Sternal Reconstruction with Titanium Prosthesis for Complicated Sternal Dehiscence with Right Ventricle Herniation after...
14/04/2025

Sternal Reconstruction with Titanium Prosthesis for Complicated Sternal Dehiscence with Right Ventricle Herniation after Cardiac Surgery: A Case Report

J Chest Surg 2025; 58(2): 60-64
https://doi.org/10.5090/jcs.24.087

This case report describes a patient who developed repeated sternal dehiscence and right ventricular herniation after cardiac surgery. To stabilize the chest wall and protect the heart, a multidisciplinary team successfully reconstructed the sternum using a pre-planned titanium prosthesis shaped with a 3D-printed model. The patient had a good postoperative recovery, showing that this method could be a promising option for managing complex sternal complications​.

Recommendation for Clinical T Staging in Patients with Non-Small Cell Lung Cancer: Volumetric Measurement: A Retrospecti...
23/03/2025

Recommendation for Clinical T Staging in Patients with Non-Small Cell Lung Cancer: Volumetric Measurement: A Retrospective Study from Turkey

This study evaluated the usefulness of 3D volumetric measurements for clinical T staging in non-small cell lung cancer (NSCLC), as an alternative to the traditional diameter-based method. Results showed that volumetric staging led to significant differences in tumor classification and provided more accurate predictions of overall survival, especially in early-stage tumors. The findings suggest that volumetric staging could enhance prognostic accuracy and may serve as a superior alternative to diameter-based T staging in NSCLC.

https://doi.org/10.5090/jcs.24.052
J Chest Surg 2025; 58(2): 51-57

Current Trends in the Epidemiology and Treatment of Esophageal Cancer in South Korea.J Chest Surg 2025; 58(1): 15-20http...
15/01/2025

Current Trends in the Epidemiology and Treatment of Esophageal Cancer in South Korea.

J Chest Surg 2025; 58(1): 15-20
https://doi.org/10.5090/jcs.24.078

This study focuses on the epidemiology and treatment trends of esophageal cancer in South Korea, where it ranks as the 18th most common cancer and the 10th leading cause of cancer-related deaths. The incidence of esophageal cancer has gradually declined, with a notable increase in early-stage diagnoses, contributing to improved 5-year survival rates.

Starting January 2025, Dr. Seong Yong Park, MD, PhD, serves the role of Editor-in-Chief for the Journal of Chest Surgery...
06/01/2025

Starting January 2025, Dr. Seong Yong Park, MD, PhD, serves the role of Editor-in-Chief for the Journal of Chest Surgery (JCS). Over the past five years, Dr. Park has served on the Publications Committee of the Korean Society for Thoracic and Cardiovascular Surgery and has worked as an Associate Editor for JCS since last year.

Dr. Park graduated from Yonsei University and has held positions as an Assistant Professor and Associate Professor at Ajou University and Yonsei University. Currently, he works at Samsung Medical Center, specializing in thoracic surgery, particularly in esophageal and lung cancer. He has expressed his dedication to advancing JCS to achieve SCIE indexing in the near future.

Address

Seoul
04501

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 18:00

Telephone

+82234827869

Alerts

Be the first to know and let us send you an email when Journal of Chest Surgery posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category